Adjuvant therapy of testis cancer: the role of vinblastine and bleomycin.
We studied 37 patients with testis cancer who received adjuvant chemotherapy with vinblastine and bleomycin. These patients included 5 with stage III disease who were down staged by a surgical procedure and 32 with stage II disease. Of the 32 patients 26 had stage IIB tumors, showing gross nodal disease. There have been 4 deaths, 2 of disease and 2 as a result of therapy. The remaining patients are free of disease and the estimated 5-year survival is 85 per cent.
D000293:Adolescent; D000328:Adult; D001761:Bleomycin / Q000008:administration & dosage*; D002369:Castration; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D006801:Humans; D008197:Lymph Node Excision; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D013736:Testicular Neoplasms / Q000188:drug therapy* / Q000601:surgery; D014747:Vinblastine / Q000008:administration & dosage*
D001761:Bleomycin; D014747:Vinblastine